| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/02/2006 | EP1685124A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 08/02/2006 | EP1684775A1 Use of extracts from the pelargonium species |
| 08/02/2006 | EP1684753A2 Neuromuscular blocking agents and antagonists thereof |
| 08/02/2006 | EP1605947B1 Use of pteridine derivatives for the treatment of increased intracranial pressure |
| 08/02/2006 | EP1529043B1 Process for the preparation of 2-methyl piperazine derivatives. |
| 08/02/2006 | EP1505965B1 Use of the metabolite of valsartan to inhibit platelet aggregation |
| 08/02/2006 | EP1478380B1 Use of tyrosine kinase inhibitors for treating cns disorders |
| 08/02/2006 | EP1435971B1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 08/02/2006 | EP1435941B1 Wortmannin analogs and methods of using same |
| 08/02/2006 | EP1434766B1 Piperidine compounds as muscarinic antagonists |
| 08/02/2006 | EP1412362B1 THIENO¬2,3-d|PYRIMIDINEDIONES AS INHIBITORS OF T-CELLS PROLIFERATION |
| 08/02/2006 | EP1381614B1 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO¬2,3-f|QUINOXALINE |
| 08/02/2006 | EP1372737B1 Preparation for the prophylaxis of restenosis |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1330459B1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 08/02/2006 | EP1326617B1 Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma |
| 08/02/2006 | EP1296656B1 Method for preparing a composition |
| 08/02/2006 | EP1276485B1 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | EP1001785B1 Use of colchinol derivatives as vascular damaging agents |
| 08/02/2006 | EP0975360B1 Bovine respiratory and enteric coronovirus as a vaccine |
| 08/02/2006 | EP0939621B1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 08/02/2006 | EP0862428B1 Ginkgolides for inhibition of membrane expression |
| 08/02/2006 | EP0751962B1 Methods for inhibiting cd14 mediated cell activation |
| 08/02/2006 | CN1813188A Diagnosis of carcinomas |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812812A Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 08/02/2006 | CN1812801A Composition for lowering serum uric acid level |
| 08/02/2006 | CN1810958A Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/02/2006 | CN1810836A Human proinsulin-KGD chimeric peptide as new recombinat antithrombotic with thrombocyte GP-IIb-IIIa receptor specificity |
| 08/02/2006 | CN1810790A Non-metal salt of Glicididazole and its prepn |
| 08/02/2006 | CN1810287A Chinese medicine for resisting kinetic fatigue |
| 08/02/2006 | CN1810254A New medicinal use of paeonidin |
| 08/02/2006 | CN1810236A Liposome preparation of garlicin |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 08/02/2006 | CN1267434C Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene |
| 08/02/2006 | CN1267431C Substituted quinazoline derivatives and their use as inhibitors |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267427C Process for production of citalopram |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267412C CCR-3 receptor antagonists V |
| 08/02/2006 | CN1267408C Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267140C Method for preparing compound medicinal liquor for nourishing yin |
| 08/02/2006 | CN1267128C Orally disintegrating tablet of 'Huoxiang Zhengqi' and its preparation process |
| 08/02/2006 | CN1267114C Midicial herbal compound for prevention and treatment of diabetes |
| 08/02/2006 | CN1267091C Anti-influenza agent |
| 08/02/2006 | CN1267087C Pharmaceutical tablet |
| 08/02/2006 | CN1267085C Modifying the fatty acid composition of cell membranes of organs and tissues |
| 08/02/2006 | CN1267079C Herbal composition for improving oral hygiene |
| 08/02/2006 | CN1267024C Tryptophan source from plants and uses therefor |
| 08/01/2006 | USRE39219 Isolated Dna |
| 08/01/2006 | US7084270 Pyrimido compounds having antiproliferative activity |
| 08/01/2006 | US7084243 Glucagon-like peptide-1 analogs |
| 08/01/2006 | US7084242 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol |
| 08/01/2006 | US7084240 Crystallization of IGF-1 |
| 08/01/2006 | US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | US7084167 A secondary aminemethyl-indole derivatives, for treating diseases or physiological disorders; calcimimetic activity |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
| 08/01/2006 | US7084160 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084149 Anticancer agents; antitumor agents |
| 08/01/2006 | US7084148 Analgesics; antipyretics; antiinflammatory agents |
| 08/01/2006 | US7084147 Anilinoquinazaolines as protein tyrosine kinase inhibitors |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | US7084123 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/01/2006 | US7084120 Prodrugs of DP IV-inhibitors |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084109 FVIIa antagonists |
| 08/01/2006 | US7083964 Using chromatographic columns comprising styrene/divinyl-benzene and/or ceramic hydroxylapatite base for isolation of clostridial catalytic polypeptides |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083785 Tumor necrosis factor family and its blocking agent |
| 08/01/2006 | CA2379903C Novel benzotriazoles anti-inflammatory compounds |
| 08/01/2006 | CA2360024C Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 08/01/2006 | CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes |
| 08/01/2006 | CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/01/2006 | CA2245823C Farnesyl transferase inhibitors |
| 08/01/2006 | CA2192456C Pyridylbisphosphonates for use as a therapeutical agent |
| 08/01/2006 | CA2176720C Novel enzyme inhibitors, their synthesis, and methods for use |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 07/27/2006 | WO2006078422A2 Methods for modulating tumor growth and metastasis |
| 07/27/2006 | WO2006078059A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | WO2006078006A1 Indole compound and pharmaceutical composition containing the same |
| 07/27/2006 | WO2006077972A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 07/27/2006 | WO2006077954A1 Remedy for neurological disease |
| 07/27/2006 | WO2006077851A1 Quinolone derivative and salt thereof |
| 07/27/2006 | WO2006077846A1 Therapeutic agent for attention-deficit hyperactivity disorder |